HLB Therapeutics Co.,Ltd.
115450
Peringkat dalam Saham
#18716
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Harga Saham
$1.87
Kapitalisasi Pasar
$176.28M
Perubahan (1 hari)
-0.55%
Perubahan (1 tahun)
-10.80%
Negara
KR
Perdagangan HLB Therapeutics Co.,Ltd. (115450)
Kategori
Healthcare
Kapitalisasi pasar dari HLB Therapeutics Co.,Ltd.(115450)
Kapitalisasi Pasar: $176.28M
Per October 2026, HLB Therapeutics Co.,Ltd. memiliki kapitalisasi pasar sebesar $176.28M. Ini menjadikan HLB Therapeutics Co.,Ltd. sebagai perusahaan 18716th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar HLB Therapeutics Co.,Ltd. dari 2010 hingga 2026
115450 dibandingkan dengan 5 teratas stocks paling populer
